Accolade Inc (STU:4NE1)
€ 3.42 0.12 (3.64%) Market Cap: 275.12 Mil Enterprise Value: 279.28 Mil PE Ratio: 0 PB Ratio: 0.70 GF Score: 61/100

Accolade Inc At EVOLVE Q&A Call Transcript

Sep 21, 2021 / 05:15PM GMT
Release Date Price: €37.4 (-1.58%)
Operator

Thank you for standing by, and welcome to the Accolade Evolve Q&A call. (Operator Instructions) As a reminder, today's program is being recorded.

I would now like to introduce your host for today's program, Todd Friedman, Senior Vice President of Investor Relations. Please go ahead, sir.

Todd Friedman
Accolade, Inc. - SVP of IR

Thanks, Jonathan, and welcome, everyone to our Q&A following this morning's keynotes. I hope you're all be able to listen to the Evolve keynotes. I'm happy to be hosting the call today with Megan Torres, our VP of Corporate Marketing. With Megan and I on the call today are our Chief Executive Officer, Rajeev Singh; our Chief Financial Officer, Steve Barnes; and Dr. Shantanu Nundy, our Chief Medical Officer.

A reminder for everyone that today's call is really meant a follow-up on this morning's keynotes. We'll be reporting earnings on October 7, and we'll address your financial questions then. Also in the interest of time, please limit yourself to 1 question, and we'll come back around the queue time permitting

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot